The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients (Q60895640)
Jump to navigation
Jump to search
scientific article published on 21 December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients |
scientific article published on 21 December 2010 |
Statements
The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients (English)
Susanna Leskelä
Iván Muñoz
Andrés Redondo
Javier de Santiago
21 December 2010